Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
about
Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancerG Protein-Coupled Receptor Signaling in Stem Cells and CancerCyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during TherapyProstaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functionsAssociation of EP2 receptor and SLC19A3 in regulating breast cancer metastasis.Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.EP4 receptor promotes invadopodia and invasion in human breast cancer.Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis.Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity.Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition.Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.Expression of prostaglandin E2 and EP receptors in human papillary thyroid carcinoma.COX-2 induces oncogenic micro RNA miR655 in human breast cancer.The Anti-Cancer Effects of Frondoside A.COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
P2860
Q26828414-C6774175-75F1-42EF-A55A-191169B87371Q26853233-76CBCD59-8F5E-4DBC-B0A5-7F9C2B544EBAQ28073252-D12613DC-2A34-4E31-8C84-A2D3F3BB7F97Q34494513-25F5D4CF-FB7D-4EA1-A3EF-8A6C96F9E84CQ35713568-15BCB11C-C4A6-4152-A7AD-43BF3C8F0EDAQ36420170-69EF57A4-8E02-4806-ABC5-3DF3A9F74241Q37701635-8FB8E8B1-1738-4CDB-A3F7-CE18D592F5FFQ38720995-B590354C-8BC8-4229-AD65-8E0142CF3876Q38925669-DF8CE842-8561-44AF-A1E1-58DD0FED584CQ39834032-E6CE96B7-ECFE-43BD-8E74-0D3E6BE3B23AQ40160860-5F5D7BE1-CC07-4F76-9589-210B6B5451FFQ40852202-62E3D951-3634-468F-8A2D-8793B02AFBB9Q47976968-A2442184-9717-4C5E-8A66-98DB6AAA8EE1Q49409776-47236575-79B9-43B2-A8F5-2A6978E93A6BQ49803778-B50DE96A-27DB-4D61-B1F7-B0C69517A2EEQ51703393-B20E5F16-5498-4B2A-83C1-D2BBAC38D016Q53176610-E2159EAE-7E3D-4267-9C99-E23DBDBF6B57Q55230010-6AF07325-865C-4EE5-B9F0-9828E55E190E
P2860
Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@en
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@nl
type
label
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@en
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@nl
prefLabel
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@en
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@nl
P2093
P2860
P1476
Prostaglandin E receptor EP4 i ...... lls with stem-like properties.
@en
P2093
Amy Fulton
Jocelyn Reader
Keyata Thompson
Namita Kundu
Olga Goloubeva
Paul Staats
Peter Collin
Stuart Martin
Tyler Kochel
Xinrong Ma
P2860
P2888
P356
10.1007/S10549-013-2779-4
P407
P577
2013-11-27T00:00:00Z